HMTC yields 49.50% · PFE yields 6.13%● Live data
📍 HMTC pulled ahead of the other in Year 1
Combined, HMTC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTC + PFE for your $10,000?
Homasote Company manufactures and sells building and industrial products for the construction and manufacturing industries in the United States. The company operates through two divisions, Millboard and Industrial. The Millboard division provides wall and floor sound insulation products, roof and floor deckings, concrete expansion joints and forming boards, and finished interior panels. The Industrial division offers various shapes and coated strips for product separation and breakage reduction that protects customer's products during interplant transport primarily for use in glass, paper, and metal industries, as well as provides packaging products to end-users, appliance manufacturers, and office furniture makers. The company's products are applied in various applications that include sound control, basement and concrete slab conversions, cathedral ceilings, fire-rated products, concrete forming, decorative/tackable panels, floors, floor and surface protection products, hobbies, house and workshops, ice rink conversions, roofs and ceilings, shock absorptions, thermal insulations, and walls, as well as construction and renovation of multi-family dwellings, commercial office buildings, educational facilities, single-family dwellings, and retail establishments. It serves building material wholesalers and contractors, and industrial manufacturers. The company also exports its products to Canada and internationally. Homasote Company was founded in 1909 and is based in West Trenton, New Jersey.
Full HMTC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.